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Abstract
Background: Previous studies of acupuncture show favourable results for both subjective and objective outcomes of
dry eye. However, firm conclusions could not be drawn from these studies because the quality of the trials was too low
to establish concrete evidence. Therefore, this study was designed both to avoid the flaws of the existing trials and to
assess the effectiveness, cost-effectiveness and qualitative characteristics of acupuncture treatment for dry eye.
Methods/design: One hundred fifty participants with dry eye will be recruited into three independent hospitals
from different areas: Korea Institute of Oriental Medicine, DongGuk University Ilsan Oriental Hospital and Dongshin
University Gwangju Oriental Hospital. The number of participants required was calculated from the data of a
previous, relevant study. These patients will be randomly allocated into acupuncture treatment or artificial tear
groups. Either 17 acupuncture points (bilateral BL2, GB14, TE 23, Ex1, ST1, GB20, LI4, LI11 and single GV23) will be
used 3 times a week or disposable artificial tear drops (Refresh Plus®, ALLERGAN) will be provided for use at least
once a day for 4 weeks. The ocular surface disease index (OSDI), tear film break-up time (TFBUT), Schirmer I test,
visual analogue scale (VAS) for self-assessment of ocular discomfort, general assessment (by both acupuncture
practitioners and participants) and quality of life (QOL) through the Measure Yourself Medical Outcome Profile-2
(MYMOP-2) will be assessed for approximately 3-months for each study participant. In addition, qualitative study
and cost-effectiveness of acupuncture treatment will be conducted.
Trial registration: ClinicalTrials.gov (Identifier: NCT01105221).
Background
Dry eye is not a life-threatening disease, but it is one of
the most common and irritating conditions in ophthal-
mology. Because of recent data on both the pathological
mechanism and aetiology, the definition of dry eye has
been changed from simple ocular discomfort (related to
the deficiency or hyper-evaporation of tears) to a multi-
factorial disease (with ocular discomfort and visual dis-
turbances, which are related to tear-film instability and
both the hyper-osmolarity and chronic inflammation of
the ocular surface) [1]. The overall prevalence has been
reported to be between 5 and 35 percent in different
populations [2]. The incidence is now increasing more
rapidly than other ophthalmologic diseases such as cat-
aracts, retinal disease and glaucoma [3]. This may be
related to an increase in average life expectancies, envir-
onmental pollution, and adverse events of various
ophthalmologic interventions including LASIK surgeries
and medications (including antihistamines, which serve
as a major risk factor for dry eye) [2].
Acupuncture is a widely used treatment modality for
various conditions, including ophthalmologic diseases
[4]. It is generally accepted as an effective treatment
option in clinical practices. However, neither its efficacy
nor its safety is well established. This is primarily
because the quality of the clinical trials that assess
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Well-designed, rigorous research is needed to establish
the evidence for wider usage of acupuncture, including
for the treatment of dry eye [5].
In acupuncture research, selecting an appropriate con-
trol (including sham acupuncture) is a significant chal-
lenge to overcome. Several types of sham acupuncture
methods have been developed, but it is not easy to main-
tain effective masking for participants when using these
modalities. It is also difficult to exert a placebo effect that
is distinct from real (verum) acupuncture [6]. In addition,
a recent review about acupuncture research reported that
sham acupuncture has a tendency to show equivalent effi-
cacy compared to verum acupuncture [7]. Therefore, it
may be easy to draw a hasty conclusion (i.e. that acupunc-
ture has either only a small or no specific effect) in sham-
controlled clinical trial designs. Comparative-effectiveness
studies using either usual care or standard treatment
groups has its own value because it reflects real-world
clinical conditions rather than research conducted under
more ideal experimental conditions [8,9].
When we consider acupuncture as an effective inter-
vention for dry eye, it becomes important to question
both what components would be relevant for evaluating
therapeutic effects and what benefits would be gained
from treatment [10]. Recent research on complementary
and alternative medicine examines effectiveness by using
mixed-method approaches to show both the qualitative
factors and the economic values of the interventions
[8,11].
With this in mind, we designed a multicentre, rando-
mised, controlled trial that compares acupuncture treat-
ment with an artificial tear drop treatment (as an active
control). We also added mixed-method analyses for
both the cost-effectiveness and the qualitative study for
a mixed method approach.
Study aims
The primary aim of this study is to determine the effec-
tiveness of acupuncture treatment for dry eye. The null
hypothesis is that changes in the ocular surface disease
index (OSDI) are equal in both the acupuncture treat-
ment group and the artificial tear drop group after
4 weeks of treatment.
Methods/Design
This study is a randomised, active-intervention con-
trolled (using artificial tear drops), multicentre trial.
Three clinical research centres in Korea will participate
in this trial: Korea Institute of Oriental Medicine (Dae-
jeon University Hospital), DongGuk University Ilsan
Oriental Hospital and Dongshin University Gwangju
Oriental Hospital. Eligible participants will be randomly
allocated into either of the two groups (acupuncture or
artificial tear drop) and will receive treatment for
4 weeks. Ophthalmologic tests and questionnaires for
both ocular symptoms and quality of life will be assessed
for up to 13 weeks after the first visit (Figure 1). Addi-
tional studies will proceed with the main outcome ana-
lyses (cost-effectiveness and qualitative factors).
Eligibility Criteria
We will include patients who have dry eye symptoms
(e.g. ocular itching, foreign body sensation, burning,
pain and dryness, visual disturbance, ocular redness and
sensation of tearing in a single eye or in both eyes) of at
least moderate severity (i.e. tear film break-up time
[TFBUT] is below 10 seconds and Schirmer I test result
is below 10 mm/5 minutes) [12]. Participants will be
excluded if they have prominent pathological changes of
the eyelid, eyelashes, eyeball or eye accessories due to
acute infection; Stevens-Johnson syndrome; Vitamin A
deficiency; external injuries; a history of surgical opera-
tion related to the eye in the previous three months;
punctual occlusion; sequelae of facial palsy; usage of
anti-inflammatory eye dropsw i t h i nt w ow e e k sb e f o r e
entry; pregnancy; or usage of herbal medicine,
Figure 1 Study Flow Chart.
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entry. In addition, usage of contact lenses within 2
weeks before entry, and throughout the study, is prohib-
ited. The eligibility were assessed by physicians and
ophthalmologists [13].
Sample size
The results from a previous study were used to calculate
the sample size [13]. The mean difference and standard
deviation (SD) of OSDI after acupuncture treatment were
17.61 and 15.61, respectively. According to another clinical
trial with artificial tear drop, the supposed mean and SD of
the artificial tear group were 11.3 and 6.3, respectively
[14]. A two-sided 5% significance level and 80% power
were considered, and the following equation was used:
n
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za/2 = z0.025 = 1.96; z1-b = z0.8 = 0.84
Approximately 60 participants in each group were cal-
culated to be required. Therefore, estimating a 20%
dropout rate, 75 participants will be recruited into each
group. Among the 3 participating centres, all located in
Korea, approximately 50 participants will be assigned to
each to ensure an even distribution.
Randomisation and Allocation Concealment
Random numbers will be generated by a computerised
random-number generator through the block-randomi-
sation method of the SAS package (Version 9.1.3; SAS
institute Inc.) for sequence generation. A clinical
research associate (CRA) will make opaque blinded
assignment envelopes (with consecutive numbers) and
deliver them to each participating centre. The block size
and treatment-assignment table will not be available to
the researchers until the end of the study.
Random allocation will be performed at the second
visit for each participant. According to the number
assigned to a participant, the corresponding envelope
will be opened in front of the participant to reveal treat-
ment. Either acupuncture or artificial tear drop treat-
ments will be initiated at the second visit after the
assignment. Objective outcomes (i.e. Schimer test and
TFBUT) will be examined by different ophthalmologists,
while self-reported outcomes (e.g. OSDI, visual analogue
scale (VAS), quality of life (QOL), and general assess-
ment) will be assessed by different outcome assessors.
Intervention
Acupuncture treatment
Certified acupuncture practitioners who have a mini-
mum of 7 years of training and 3 years of clinical
experience will perform the acupuncture treatments.
They will take a one-day training course for this trial.
This course will cover the study protocol, techniques for
acupuncture treatment, the recording method for the
clinical record form (CRF), and basic information about
clinical research, a researcher’s duty and research moni-
toring. The relationship between patients and practi-
tioners can be an important factor when assessing the
outcomes of acupuncture research [15]. Therefore,
interactions between acupuncture practitioners and par-
ticipants will be strictly limited, except when reporting
adverse events.
Based on a literature review and a textbook about acu-
puncture for ophthalmologic diseases or dry eye [16],
acupuncture points were chosen by an expert committee
comprised of professors and researchers that specialise
in acupuncture and ophthalmology of traditional Korean
medicine. Seventeen acupuncture points (bilateral BL2,
GB14, TE 23, Ex1, ST1, GB20, LI4, and LI11 and single
GV23) will be located according to the WHO Standard
Acupuncture Point Locations in the Western Pacific
Region [17]. These will then be treated with 0.20*30
mm disposable acupuncture needles (Dongbang Co.,
Korea). The ‘deqi’ sensation will be induced by twisting
acupuncture and needles will be retained for 20 minutes
before removal. Participants will have acupuncture treat-
ments three times per week for four weeks.
Active comparator group using artificial tear drops
Artificial tear is one of the first choices in treatment for
dry eye. Because the strategy for treating dry eye is to
ease ocular discomfort and to improve quality of life,
and to recover the ocular surface from chronic inflam-
mation and tear film instability [18], artificial tear can
be recommended as an active treatment. According to a
survey report of ophthalmologists, preservative-free arti-
ficial tear was the most frequently selected medication
for moderate to severe dry eye patients among various
treatment modalities in Korea [19]. In this context, we
chose preservative-free artificial tear as an active com-
parator intervention in this trial.
Participants allocated to this group will be offered pre-
servative-free and one-day-use artificial tear drops
(Refresh Plus®, ALLERGAN) and then educated on how
to use them. According to the participants’ discomfort
from dry eye symptoms, it is recommended that the tear
drops can be used at least once a day for four weeks.
A diary of both the frequency and quantity of drops
used will be collected at every visit.
In both groups, other treatments for dry eye will be
forbidden during the study period. These other treat-
ments include different types of artificial tear drops,
drugs, supplements (e.g. cyclosporine, corticosteroids,
biological tear substitute, and oestrogen), and alternative
treatments (e.g. herbal medicine, acupuncture, and cup-
ping therapy). However, participants will be allowed to
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up period. The usage of these treatments will be
reported during the follow-up period.
Primary outcome measurement
T h eO S D Ii saq u e s t i o n n a i r et h a tc o n s i s t so ft w e l v e
questions about ocular irritation and the effect of dry
eye on vision [20]. It will be assessed at the first, third,
fifth, ninth and thirteenth week. For every question, par-
ticipants will provide a score between zero and four,
where zero equals “none of the time” and four equals
“all of the time”. OSDI scores will be calculated accord-
ing to the following formula: OSDI = [(sum of scores
for all questions answered)*100]/[(total number of ques-
tions answered)*4]. The Korean version of OSDI has not
been validated yet. However, there is no available tool
for evaluating dry eye that validation test for translation
was finished about in Korea. So we will use the Korean
version of OSDI which has been widely used for practice
and research since 2006, in spite of these limitations
[13,21,22].
Secondary outcome measurement
A VAS for self assessment of ocular discomfort will be
reported by participants. Ocular symptoms related to
dry eye (e.g. ocular itching, foreign body sensation,
burning, pain and dryness, blurred vision, sensation of
photophobia, ocular redness, and sensations of tearing)
will all be reported using a standard 100-mm VAS scale.
QOL questionnaire of the Measure Yourself Medical
Outcome Profile-2 (MYMOP-2) will be used to assess
dry-eye-related QOL [23,24]. A seven-point Likert scale
(from zero-’Excellent’ to six-’Worst’) will be used. The
questionnaire is: “During last week, how would you
express your quality of life related to dry eye overall?”
The VAS and questionnaire for QOL will be assessed at
the first, third, fifth, ninth and thirteenth week.
The Schirmer I test (with anaesthesia) is a diagnostic
method to measure the basic quantity of tear secretion
[25]. After application of local anaesthesia, Schirmer test
paper (Color BarTM Eagle Vision, USA) will be placed
in the lateral third of the lower eyelid for five minutes
while the participants’ eyes are closed.
Tear film break-up time (TFBUT) is a method for
observing tear film stability [26,27]. Sodium fluorescein
(2.5%) will be applied to both eyes, and the tear break-
up time (i.e. the interval between the last complete blink
and the first appearance of a dry spot or disruption in
the tear film) will be measured. Both the Schimer test
and TFBUT will be assessed at the first, fifth and thir-
teenth week.
Acupuncture practitioners and participants will evalu-
ate general improvement of dry eye-related symptoms
using a five-grade scale: excellent, good, fair, poor and
aggravation. This will be assessed after the end of the
treatment period (the fifth week).
Additional study
A nested, questionnaire-based, qualitative study will be
conducted to explore the participants’ reason for enrol-
ling in this randomized controlled trial, experiences of
dry-eye, and perceived changes after either acupuncture
or artificial tear drop treatment. A questionnaire with
open-ended questions will be distributed to all partici-
pants at the first, fifth and ninth week. They will be
encouraged to write their responses in a comfortable
environment. At baseline, pa t i e n t si nb o t hg r o u p sw i l l
be asked how dye eye affects their lives and why they
participated in this trial. At the fifth week, they will be
asked how they feel after acupuncture treatment (or
artificial tear drop treatment) and how they feel about
being provided acupuncture treatment (or artificial tear
drop treatment). At the ninth week, they will be asked
how dry eye currently affects their lives and whether
there was any change in their daily lives after treatment
(acupuncture or artificial tear drops). Completed ques-
tionnaires will be collected at the next visit. Data will be
analysed by a systematic text condensation method
using the patients’ written responses.
Cost-effectiveness will be analysed using the OSDI
scores and comparing the cost of acupuncture with arti-
ficial tear drops for the two groups during the four-
week treatment period. Additionally, the cost of dry-eye
and other treatments (including acupuncture) for all of
the participants during the follow-up period will be
recorded and analysed.
Statistical analysis
Statistical analysis will be conducted on an intention-to-
treat basis with a 95% confidence interval using the SAS
statistical package (SAS® Version 9.1, SAS institute. Inc.,
Cary, NC). Missing values of drop-out participants will
be imputed by the last observation carried forward
(LOCF) method. Baseline characteristics will be dis-
played as the mean ± SD for continuous data or n (%)
for categorical data. Because patient expectations may
affect the treatment outcome [28], patient expectations
(reported on a nine-point Likert scale before assignment
of intervention) will also be compared between the two
groups.
For analysis of baseline characteristics, either two-sam-
ple t tests or Wilcoxon rank sum tests for continuous
data and Chi-squared tests or Fisher’s exact tests for cate-
gorical data will be conducted after the test for normality.
ANCOVA (Analysis of Covariance) will be used to test
whether outcome measures (OSDI score, TFBUT, Schi-
mer test result, QOL, VAS for self-assessment of ocular
discomfort) differ between conditions when controlling
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repeated measure analysis of variance will be performed
to show changes in trends.
Adverse events
All unexpected responses related to acupuncture treat-
ment or use of artificial tear drops will either be
reported to the investigators by participants or be exam-
ined by acupuncture practitioners. Local, general and
psychological adverse events are possible as a result of
acupuncture treatments [13]. Irritability, pain and red-
ness of eyes, headache, and blurred vision are recognised
as common adverse reactions to artificial tear drops. If
serious adverse events (SAE) occur, experimental treat-
ments will be stopped immediately, and appropriate
treatments will be offered. The type and frequency of
adverse events will be reported for each group.
Ethics
This research protocol was approved by the institutional
review board (IRB) of each trial centre (Daejeon Univer-
sity Hospital, Dongguk University Ilsan Oriental Hospital
and Dongshin University Gwangju Oriental Hospital).
Every participant will give informed consent before the
start of this trial.
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